Self-administration of a novel subcutaneous bradykinin b(2) receptor antagonist, icatibant, as an effective treatment option in patients with hereditary angioedema

Benzer Materyaller

• Icatibant, a New Bradykinin-Receptor Antagonist, in Hereditary Angioedema
  Yazar:: Cicardi, M., ve diğerleri
  Baskı/Yayın Bilgisi: (2010)
• Early presentation of clinical hereditary angioedema symptoms in an infant
  Yazar:: Pham, Hoang, ve diğerleri
  Baskı/Yayın Bilgisi: (2014)
• 164 Treatment of Acquired Angioedema with the Bradykinin Receptor Antagonist Icatibant
  Yazar:: Siani, Maria Concetta, ve diğerleri
  Baskı/Yayın Bilgisi: (2012)
• Safety and efficacy of icatibant self-administration for acute hereditary angioedema
  Yazar:: Boccon-Gibod, I, ve diğerleri
  Baskı/Yayın Bilgisi: (2012)
• Therapeutic trial in hereditary angioedema type III: Icatibant
  Yazar:: Garro, Laila Sabino, ve diğerleri
  Baskı/Yayın Bilgisi: (2015)